Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Zydus Lifesciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
532321
INE010B01027
145.1076344
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
ZYDUSLIFE
35.49
95380.92
EPS(TTM)
Face Value(
)
Div & Yield %:
26.71
1
0.64
Particulars(INCOME)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Mar 2018
(
Cr)
Sales Turnover
8731.60
7836.90
7780.00
6347.40
6037.40
5822.60
Excise Duty
0.00
0.00
0.00
0.00
0.00
12.70
Net Sales
8731.60
7836.90
7780.00
6347.40
6037.40
5809.90
Other Income
548.40
178.70
89.30
908.70
605.20
207.90
Stock Adjustments
-105.10
46.90
148.30
-15.50
86.00
186.90
Total Income
9174.90
8062.50
8017.60
7240.60
6728.60
6204.70
EXPENDITURE :
Raw Materials
3066.20
2917.10
2499.70
1936.20
1950.20
1882.60
Power & Fuel Cost
278.60
245.20
193.20
208.40
200.20
172.00
Employee Cost
1321.90
1204.90
1147.30
1077.40
961.20
826.00
Other Manufacturing Expenses
332.50
381.10
363.40
327.30
347.00
307.60
Selling & Administrative Expenses
1041.50
958.40
1009.10
925.30
755.00
813.90
Miscellaneous Expenses
335.20
578.30
594.40
486.20
280.00
348.40
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
6375.90
6285.00
5807.10
4960.80
4493.60
4350.50
Operating Profit
2799.00
1777.50
2210.50
2279.80
2235.00
1854.20
Interest
278.20
134.90
70.90
233.90
89.60
63.90
Gross Profit
2520.80
1642.60
2139.60
2045.90
2145.40
1790.30
Depreciation
488.60
478.70
451.10
428.90
358.20
293.10
Profit Before Tax
2032.20
1163.90
1688.50
1617.00
1787.20
1497.20
Tax
461.80
260.20
303.30
164.10
335.40
318.30
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
41.20
45.80
-91.00
40.00
-33.90
88.10
Reported Net Profit
1529.20
857.90
1476.20
1412.90
1485.70
1090.80
Extraordinary Items
-92.41
-237.64
-156.95
-52.67
74.44
34.24
Adjusted Net Profit
1621.61
1095.54
1633.15
1465.57
1411.26
1056.56
Adjustment below Net Profit
1.80
-6.90
-15.30
-6.00
-294.40
-9.60
P & L Balance brought forward
9289.40
8796.90
7336.00
6645.70
5812.70
4731.50
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
253.00
358.50
0.00
716.60
358.30
0.00
P & L Balance carried down
10567.40
9289.40
8796.90
7336.00
6645.70
5812.70
Dividend
0.00
0.00
0.00
0.00
0.00
358.31
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
600.00
250.00
350.00
350.00
350.00
350.00
Dividend Per Share(Rs)
6.00
2.50
3.50
3.50
3.50
3.50
Earnings Per Share-Unit Curr
15.11
8.38
14.42
13.80
14.51
10.65
Earnings Per Share(Adj)-Unit Curr
15.11
8.38
14.42
13.80
14.51
10.65
Book Value-Unit Curr
134.78
129.30
124.46
109.96
83.68
75.64
Book Value(Adj)-Unit Curr
134.78
129.30
124.46
109.96
83.68
75.64